Can Fite BioPharma : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON June 26, 2024 To the shareholders of Can-Fite BioPharma Ltd.: ...
Stay updated with breaking news from Stadler Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON June 26, 2024 To the shareholders of Can-Fite BioPharma Ltd.: ...
PETACH TIKVA, Israel, February 28, 2024--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it received a Notice of Allowance from the Canadian Intellectual Property Office for its patent application titled "An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation". This invention addresses the use of Namodenoson for the